NextCure CSO resigns effective Sept 1, 2025; no replacement named

NextCure, Inc.

Solomon Langermann, Ph.D., resigned as Chief Scientific Officer, effective September 1, 2025.
Resignation was not due to any disagreement with the Company or its operations.
No successor has been announced at this time.
Board and Company thanked Dr. Langermann for his contributions.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.